Islington Pharma Limited
09526893
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 07/04/2015
DIRECTOR
BRITISH · UNITED KINGDOM · Age 50
Also on 1 other board
Persons with Significant Control
Mr Aurangzeb Yousaf
British · United Kingdom · Age 50
Unit A, North Road, London, N7 9GL
Notified 03/04/2017
CompanyRankvs 2930+ SIC 47730 peers52
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/04/2025
Net Worth
£100
Balance sheet strength
Cash
£499k
Cash in the bank
Net Current Assets
£525k
Working capital
Current Assets
£829k
Current Liabilities
£303k
Fixed Assets
£4k
Debtors
£280k
Tax at Year End
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 2.73 | — |
| 2024 | 2.48 | — |
| 2023 | 2.24 | — |
| 2022 | 1.96 | +£25k |
| 2021 | 1.78 | +£3k |
| 2020 | 1.89 | +£20k |
| 2019 | 1.66 | +£147k |
| 2018 | 1.25 | — |
Derived from filed accounts. Not audited figures.